{"id":257520,"date":"2026-05-28T05:06:00","date_gmt":"2026-05-28T09:06:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/05\/28\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/"},"modified":"2026-05-28T05:10:17","modified_gmt":"2026-05-28T09:10:17","slug":"validation-to-velocity-japans-pharma-model-comes-under-execution-pressure","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/05\/28\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/","title":{"rendered":"Validation to velocity: Japan\u2019s pharma model comes under execution pressure"},"content":{"rendered":"<p><a href=\"https:\/\/www.pharmaceutical-technology.com\/features\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/\">Validation to velocity: Japan\u2019s pharma model comes under execution pressure<\/a><\/p>\n<p><a href=\"https:\/\/www.pharmaceutical-technology.com\/features\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/\">https:\/\/www.pharmaceutical-technology.com\/features\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-05-28 05:06:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.pharmaceutical-technology.com\">www.pharmaceutical-technology.com<\/a><\/p>\n<p>                                    Japan\u2019s pharmaceutical market is the third largest in the world, following the United States and China. Credit: Vitalii Stock via Shutterstock.com.<\/p>\n<p class=\"drop-cap\">Japan\u2019s pharmaceutical industry \u2013 the world\u2019s third largest by market value after the United States and China \u2013 has long been associated with methodical development cycles and rigorous technical validation. But the sector is undergoing a gradual yet increasingly visible shift in how it evaluates external partners and drug development programmes.<\/p>\n<p>Across therapeutics, particularly complex modalities such as peptides, the defining constraint is moving from scientific feasibility to execution speed.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.pharmaceutical-technology.com\/wp-content\/themes\/goodlife-wp-B2B\/assets\/img\/globaldata_marketing_solutions_logo.svg\" alt=\"\"\/><\/p>\n<h4> Discover B2B Marketing That Performs <\/h4>\n<p>\n\t\t\t\t\t\tCombine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.\n\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\tFind out more <span><\/span><\/p>\n<p>\u201cThe \u2018how?\u2019 has given way to the \u2018how soon?\u2019\u201d explained Sharadsrikar Kotturi, chief scientific officer at Indian contract development and manufacturing organisation (CDMO) Neuland Laboratories, describing what he sees as a structural change in Japan\u2019s engagement with global pharmaceutical partners.<\/p>\n<p>Kotturi said the change was particularly visible at this year\u2019s CPHI Japan forum, where conversations shifted from technical exploration to timelines, scalability and execution certainty. The evolving atmosphere was reflected even in the dress code, with ties and polished leather shoes increasingly replaced by sneakers and more casual attire \u2013 a visible sign of Japan\u2019s&#8230;<\/p>\n<p><a href=\"https:\/\/www.pharmaceutical-technology.com\/features\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Validation to velocity: Japan\u2019s pharma model comes under execution pressure https:\/\/www.pharmaceutical-technology.com\/features\/validation-to-velocity-japans-pharma-model-comes-under-execution-pressure\/ Publish Date: 2026-05-28 05:06:00&#8230;<\/p>\n","protected":false},"author":1,"featured_media":257521,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.pharmaceutical-technology.com\/wp-content\/uploads\/sites\/24\/2026\/05\/shutterstock_2045704478.jpg","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-257520","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/257520"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=257520"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/257520\/revisions"}],"predecessor-version":[{"id":257522,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/257520\/revisions\/257522"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/257521"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=257520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=257520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=257520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}